New, previously unpublished clinical data have been presented at ISSCR 2026 demonstrating that transplanted human neural ...

New, previously unpublished clinical data was presented today at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for at least one year following subretinal ...

New, previously unpublished clinical data was presented today at ISSCR 2026 demonstrating that transplanted human neural progenitor cells survived for ...

A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...

The firm announced it has aligned with the US Food and Drug Administration on the design of the Phase III study, which could support a biologics license application.

Biosimilar anti-VEGF agents matched the reference ranibizumab in vision outcomes and safety across retinal diseases in India, at a lower cost. More than half of India's health care spending is paid ...